81 related articles for article (PubMed ID: 15677564)
1. Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma.
Renné C; Willenbrock K; Küppers R; Hansmann ML; Bräuninger A
Blood; 2005 May; 105(10):4051-9. PubMed ID: 15677564
[TBL] [Abstract][Full Text] [Related]
2. S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cells.
Vrzalikova K; Ibrahim M; Vockerodt M; Perry T; Margielewska S; Lupino L; Nagy E; Soilleux E; Liebelt D; Hollows R; Last A; Reynolds G; Abdullah M; Curley H; Care M; Krappmann D; Tooze R; Allegood J; Spiegel S; Wei W; Woodman CBJ; Murray PG
Leukemia; 2018 Jan; 32(1):214-223. PubMed ID: 28878352
[TBL] [Abstract][Full Text] [Related]
3. Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma.
Liu WR; Shipp MA
Blood; 2017 Nov; 130(21):2265-2270. PubMed ID: 29167175
[TBL] [Abstract][Full Text] [Related]
4. Autocrine and paracrine functions of cytokines in malignant lymphomas.
Hsu SM; Hsu PL
Biomed Pharmacother; 1994; 48(10):433-44. PubMed ID: 7858153
[TBL] [Abstract][Full Text] [Related]
5. Pinpointing Functionally Relevant miRNAs in Classical Hodgkin Lymphoma Pathogenesis.
Pan Y; Cengiz R; Kluiver J; Diepstra A; Van den Berg A
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539461
[TBL] [Abstract][Full Text] [Related]
6. Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma.
Hazane Leroyer E; Ziegler C; Moulin C; Campidelli A; Jacquet C; Rubio MT; Feugier P; Pagliuca S
J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362802
[TBL] [Abstract][Full Text] [Related]
7. Hodgkin Lymphoma: A Special Microenvironment.
Opinto G; Agostinelli C; Ciavarella S; Guarini A; Maiorano E; Ingravallo G
J Clin Med; 2021 Oct; 10(20):. PubMed ID: 34682791
[TBL] [Abstract][Full Text] [Related]
8. Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma.
Bastidas Torres AN; Melchers RC; Van Grieken L; Out-Luiting JJ; Mei H; Agaser C; Kuipers TB; Quint KD; Willemze R; Vermeer MH; Tensen CP
Haematologica; 2022 Jul; 107(7):1619-1632. PubMed ID: 34382383
[TBL] [Abstract][Full Text] [Related]
9. Immune Microenvironment Features and Dynamics in Hodgkin Lymphoma.
Bertuzzi C; Sabattini E; Agostinelli C
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298847
[TBL] [Abstract][Full Text] [Related]
10. The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer.
Elkamhawy A; Lu Q; Nada H; Woo J; Quan G; Lee K
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207360
[TBL] [Abstract][Full Text] [Related]
11. Extracellular matrix and its therapeutic potential for cancer treatment.
Huang J; Zhang L; Wan D; Zhou L; Zheng S; Lin S; Qiao Y
Signal Transduct Target Ther; 2021 Apr; 6(1):153. PubMed ID: 33888679
[TBL] [Abstract][Full Text] [Related]
12. Heat Shock Proteins in Lymphoma Immunotherapy.
Albakova Z; Mangasarova Y; Sapozhnikov A
Front Immunol; 2021; 12():660085. PubMed ID: 33815422
[TBL] [Abstract][Full Text] [Related]
13. Molecular biology of Hodgkin lymphoma.
Weniger MA; Küppers R
Leukemia; 2021 Apr; 35(4):968-981. PubMed ID: 33686198
[TBL] [Abstract][Full Text] [Related]
14. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
Li C; Romero-Masters JC; Huebner S; Ohashi M; Hayes M; Bristol JA; Nelson SE; Eichelberg MR; Van Sciver N; Ranheim EA; Scott RS; Johannsen EC; Kenney SC
PLoS Pathog; 2020 Jun; 16(6):e1008590. PubMed ID: 32542010
[TBL] [Abstract][Full Text] [Related]
15. Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement.
Kwon JH; Kim KJ; Sung JH; Suh KJ; Lee JY; Kim JW; Kim SH; Lee JO; Kim JW; Kim YJ; Lee KW; Kim JH; Bang SM; Kim S; Yoon SS; Lee JS
Cells; 2019 Nov; 8(12):. PubMed ID: 31795298
[TBL] [Abstract][Full Text] [Related]
16. Plausibility of trophoblastic-like regulation of cancer tissue.
Piechowski J
Cancer Manag Res; 2019; 11():5033-5046. PubMed ID: 31213916
[No Abstract] [Full Text] [Related]
17. The scope of viral causation of human cancers: interpreting virus density from an evolutionary perspective.
Ewald PW; Swain Ewald HA
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1773):20180304. PubMed ID: 30955500
[TBL] [Abstract][Full Text] [Related]
18. Contribution of Epstein⁻Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma.
Vrzalikova K; Sunmonu T; Reynolds G; Murray P
Pathogens; 2018 Jun; 7(3):. PubMed ID: 29954084
[TBL] [Abstract][Full Text] [Related]
19. The Microenvironment in Epstein-Barr Virus-Associated Malignancies.
Tan GW; Visser L; Tan LP; van den Berg A; Diepstra A
Pathogens; 2018 Apr; 7(2):. PubMed ID: 29652813
[TBL] [Abstract][Full Text] [Related]
20. Expression of nerve growth factor and brain-derived neurotrophic factor in astrocytomas.
Liu TT; Wang H; Wang FJ; Xi YF; Chen LH
Oncol Lett; 2018 Jan; 15(1):533-537. PubMed ID: 29391888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
